Literature DB >> 7751715

Human and viral interleukin-10 in acute Epstein-Barr virus-induced infectious mononucleosis.

H Taga1, K Taga, F Wang, J Chretien, G Tosato.   

Abstract

Human interleukin 10 (hIL-10), a product of monocytes, T cells, and B cells, shares extensive structural and functional similarity with viral IL-10 (vIL-10), a product of Epstein-Barr virus (EBV) replication. With two ELISAs, one that recognizes both hIL-10 and vIL-10 and the other specific for vIL-10, IL-10 was measured in serum or plasma and in saliva from 50 patients with acute EBV-induced infectious mononucleosis and from 19 normal subjects. In serum or plasma, 60% of the patients had measurable hIL-10 and/or vIL-10 and 18% had measurable vIL-10. In saliva, 20% of the patients had detectable hIL-10 and/or vIL-10 and none had detectable vIL-10. In contrast, hIL-10 and/or vIL-10 was undetectable in all 19 normal serum or plasma samples (P < .001 vs. patient samples). Among normal saliva samples, 21% had detectable hIL-10 and/or vIL-10 but none had detectable vIL-10. Thus, most patients with acute EBV-induced infectious mononucleosis transiently have abnormally high levels of circulating IL-10.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751715     DOI: 10.1093/infdis/171.5.1347

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

Review 1.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Murine gammaherpesvirus-68-induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis.

Authors:  J W Peacock; K L Bost
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

3.  Viral, immunologic, and clinical features of primary effusion lymphoma.

Authors:  Kathryn Lurain; Mark N Polizzotto; Karen Aleman; Manisha Bhutani; Kathleen M Wyvill; Priscila H Gonçalves; Ramya Ramaswami; Vickie Ann Marshall; Wendell Miley; Seth M Steinberg; Richard F Little; Wyndham Wilson; Armando C Filie; Stefania Pittaluga; Elaine S Jaffe; Denise Whitby; Robert Yarchoan; Thomas S Uldrick
Journal:  Blood       Date:  2019-02-19       Impact factor: 22.113

4.  EBV Latency III-Transformed B Cells Are Inducers of Conventional and Unconventional Regulatory T Cells in a PD-L1-Dependent Manner.

Authors:  Héloïse Auclair; Catherine Ouk-Martin; Lilian Roland; Pauline Santa; Hazar Al Mohamad; Nathalie Faumont; Jean Feuillard; Chantal Jayat-Vignoles
Journal:  J Immunol       Date:  2019-08-21       Impact factor: 5.422

5.  Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood.

Authors:  Vivian P Young; Margarette C Mariano; Carolyn C Tu; Kathryn M Allaire; Selmir Avdic; Barry Slobedman; Juliet V Spencer
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

Review 6.  Interferon-alpha and its effects on post-transplant lymphoproliferative disorders.

Authors:  A Faro
Journal:  Springer Semin Immunopathol       Date:  1998

Review 7.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.

Authors:  G Tosato; J Teruya-Feldstein; J Setsuda; S E Pike; K D Jones; E S Jaffe
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease.

Authors:  J Setsuda; J Teruya-Feldstein; N L Harris; J A Ferry; L Sorbara; G Gupta; E S Jaffe; G Tosato
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

9.  The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.

Authors:  Simon Jochum; Andreas Moosmann; Stephan Lang; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  PLoS Pathog       Date:  2012-05-17       Impact factor: 6.823

10.  B-Cell-Rich T-Cell Lymphoma Associated with Epstein-Barr Virus-Reactivation and T-Cell Suppression Following Antithymocyte Globulin Therapy in a Patient with Severe Aplastic Anemia.

Authors:  Nobuyoshi Hanaoka; Shogo Murata; Hiroki Hosoi; Aiko Shimokado; Toshiki Mushino; Kodai Kuriyama; Kazuo Hatanaka; Akinori Nishikawa; Miwa Kurimoto; Takashi Sonoki; Yasuteru Muragaki; Hideki Nakakuma
Journal:  Hematol Rep       Date:  2015-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.